Security
PAVmed Inc. Common Stock · PAVM
PAVMNASDAQCommon stockCurrentCIK 1624326Updated Oct 26, 2026
Name history
PAXmed Inc. · through Mar 26, 2015
PAVM price & chart
Loading TradingView…
NASDAQ:PAVM on TradingView ↗In the news
Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways ↗
Recent filings
Entry into a Material Definitive Agreement · Material Modification to Rights of Security Holders
Items 1.01, 3.03, 9.01
Entry into a Material Definitive Agreement
Items 1.01, 9.01
424B5 filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
10-Q filing
Show 5 more recent filings
S-8 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Submission of Matters to a Vote of Security Holders
Items 5.02, 5.07, 9.01
SCHEDULE 13G - filed by Two Seas Capital LP regarding PAVmed Inc.
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
10-Q filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 38,069,000Source | 30,550,000Source | 40,214,000Source | 43,893,000Source | 39,413,000Source | 45,419,000Source | 52,823,000Source | 37,254,000Source | 38,812,000Source | 30,660,000Source | 33,119,000Source | 53,980,000Source |
| Property, Plant and Equipment, NetUSD | 81,000Source | 216,000Source | 73,000Source | 100,000Source | 1,331,000Source | 79,000Source | 114,000Source | 1,595,000Source | 77,000Source | 151,000Source | 1,783,000Source | 2,451,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | — | — | — | 947,000Source | — | — | 1,052,000Source | — | — | 1,424,000Source | 3,445,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | 765,000Source | 3,784,000Source | — | 25,499,000Source | 6,460,000Source | — | 25,536,000Source | 1,538,000Source | 1,185,000Source | 19,639,000Source | 39,744,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 3,000Source | 16,000Source | — | 3,000Source | 219,000Source | — | 9,000Source | 67,000Source | — | 18,000Source | 61,000Source | 17,000Source |
| Inventory, NetUSD | — | 6,000Source | — | — | 687,000Source | — | — | 410,000Source | — | — | 278,000Source | — |
| Assets, CurrentUSD | 4,191,000Source | 2,130,000Source | 4,858,000Source | 5,488,000Source | 30,207,000Source | 7,414,000Source | 3,638,000Source | 29,574,000Source | 2,557,000Source | 2,164,000Source | 24,498,000Source | 43,926,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,085,000Source | 1,343,000Source | 1,058,000Source | 1,481,000Source | 3,802,000Source | 933,000Source | 929,000Source | 3,561,000Source | 1,004,000Source | 961,000Source | 4,520,000Source | 4,165,000Source |
| Operating Lease, Right-of-Use AssetUSD | 2,131,000Source | 2,618,000Source | 1,738,000Source | 2,256,000Source | 5,771,000Source | 1,872,000Source | 2,379,000Source | 3,886,000Source | 2,002,000Source | 2,500,000Source | 4,267,000Source | 3,037,000Source |
| Other Assets, NoncurrentUSD | 51,000Source | 75,000Source | 51,000Source | 51,000Source | 1,157,000Source | 56,000Source | 51,000Source | 1,147,000Source | 56,000Source | 208,000Source | 1,147,000Source | 1,121,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 12,282,000Source | 39,937,000Source | 20,907,000Source | 12,474,000Source | 58,055,000Source | 20,431,000Source | 11,891,000Source | 57,829,000Source | 16,512,000Source | 37,693,000Source | 57,137,000Source | 43,046,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | — | 3,232,000Source | — | — | 3,151,000Source | — | — | 3,071,000Source | — | 3,316,000Source | 2,993,000Source | 2,695,000Source |
| Common Stock, Value, IssuedUSD | 23,000Source | 11,000Source | 6,000Source | 20,000Source | 10,000Source | 6,000Source | 17,000Source | 9,000Source | 1,000Source | 11,000Source | 9,000Source | 95,000Source |
| Additional Paid in CapitalUSD | 265,331,000Source | 248,200,000Source | 295,697,000Source | 263,515,000Source | 243,524,000Source | 294,788,000Source | 255,967,000Source | 237,863,000Source | 268,019,000Source | 249,143,000Source | 237,600,000Source | 216,106,000Source |
| Retained Earnings (Accumulated Deficit)USD | -256,901,000Source | -256,312,000Source | -264,505,000Source | -250,575,000Source | -320,630,000Source | -259,028,000Source | -237,268,000Source | -309,723,000Source | -258,731,000Source | -254,965,000Source | -294,433,000Source | -228,169,000Source |
| Stockholders' Equity Attributable to ParentUSD | 32,520,000Source | -4,869,000Source | 35,048,000Source | 37,530,000Source | -73,945,000Source | 39,523,000Source | 2,500,000Source | -68,780,000Source | 33,967,000Source | -2,495,000Source | -53,831,000Source | -9,681,000Source |
| Liabilities and EquityUSD | 38,069,000Source | 30,550,000Source | 40,214,000Source | 43,893,000Source | 39,413,000Source | 45,419,000Source | 52,823,000Source | 37,254,000Source | 38,812,000Source | 30,660,000Source | 33,119,000Source | 53,980,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 10,459,000Source | 37,557,000Source | 4,088,000Source | 10,506,000Source | 53,390,000Source | 3,664,000Source | 9,781,000Source | 55,015,000Source | 14,837,000Source | 35,446,000Source | 54,177,000Source | 41,200,000Source |
| Operating Lease, Liability, CurrentUSD | 557,000Source | 499,000Source | 570,000Source | 542,000Source | 1,369,000Source | 588,000Source | 528,000Source | 1,333,000Source | 573,000Source | 513,000Source | 1,565,000Source | 1,141,000Source |
| Accounts Payable, CurrentUSD | 342,000Source | 465,000Source | 1,056,000Source | 387,000Source | 1,232,000Source | 983,000Source | 369,000Source | 1,485,000Source | 678,000Source | 657,000Source | 1,786,000Source | 2,704,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,823,000Source | 2,380,000Source | 1,398,000Source | 1,968,000Source | 4,665,000Source | 1,522,000Source | 2,110,000Source | 2,814,000Source | 1,675,000Source | 2,247,000Source | 2,960,000Source | 1,846,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -9,993,000Source | -4,518,000Source | -15,741,000Source | -9,371,000Source | 55,303,000Source | -14,535,000Source | -6,062,000Source | 48,205,000Source | -11,667,000Source | -4,538,000Source | 29,813,000Source | 20,615,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 2,660,000Source | 4,543,000Source | 2,462,000Source | 2,777,000Source | 6,789,000Source | 2,093,000Source | 2,284,000Source | 6,657,000Source | 2,486,000Source | 5,176,000Source | 6,626,000Source | 3,705,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -6,011,000Source | 60,711,000Source | -6,598,000Source | -12,324,000Source | -1,064,000Source | 18,623,000Source | -2,469,000Source | 28,427,000Source | -79,263,000Source | -103,238,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 20,000Source | 43,000Source | 105,000Source | 1,198,000Source | 2,932,000Source | 2,457,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 383,000Source | 1,931,000Source | — | — | 182,000Source | 930,000Source | 1,707,000Source | 6,449,000Source | 11,139,000Source | 19,532,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 6,000Source | -8,000Source | -3,000Source | -43,000Source | 44,000Source | -183,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 303,000Source | -286,000Source | 24,000Source | -59,000Source | -918,000Source | -742,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -2,620,000Source | -1,581,000Source | -5,206,000Source | -33,554,000Source | -52,036,000Source | -70,985,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | — | — | — | 3,200,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -22,000Source | -6,000Source | -31,000Source | -16,184,000Source | 758,000Source | -4,740,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 22,000Source | 6,000Source | 31,000Source | 55,000Source | 242,000Source | 1,540,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 7,564,000Source | 3,102,000Source | 5,590,000Source | 31,284,000Source | 31,173,000Source | 38,211,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 4,922,000Source | 1,515,000Source | 353,000Source | -18,454,000Source | -20,105,000Source | -37,514,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 0Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | 917,000Source | 162,000Source | 182,000Source | 930,000Source | 1,707,000Source | — | — | — |
| Amortization of Intangible AssetsUSD | — | — | — | 82,000Source | — | — | — | — | 0Source | 559,000Source | 2,021,000Source | 1,784,000Source |
| Deconsolidation, Gain (Loss), AmountUSD | — | — | — | 72,287,000Source | — | — | — | — | 0Source | 72,287,000Source | — | — |
| DepreciationUSD | — | — | — | — | — | — | — | — | 105,000Source | 639,000Source | 911,000Source | 673,000Source |
| Equity Securities, FV-NI, Gain (Loss)USD | — | — | -4,382,000Source | 407,000Source | — | -10,643,000Source | — | 21,004,000Source | 8,483,000Source | 532,000Source | — | — |
| Gain (Loss) on Disposition of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | — | 1,000,000Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | -58,000Source | -58,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 3,505,000Source | 6,649,000Source | 4,651,000Source | 3,670,000Source | 6,356,000Source | 4,384,000Source | 16,250,000Source | 24,524,000Source | 30,947,000Source | 41,041,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | — | — | — |
| InterestExpenseNonoperatingUSD | — | — | — | — | 2,000Source | 4,000Source | 3,000Source | 4,000Source | 21,000Source | — | — | — |
| Investment Income, InterestUSD | — | — | — | — | 10,000Source | 8,000Source | 19,000Source | 8,000Source | 29,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -5,383,000Source | 64,399,000Source | -5,384,000Source | -11,921,000Source | -60,000Source | 18,968,000Source | 401,000Source | 39,791,000Source | -64,175,000Source | -88,983,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -628,000Source | -3,688,000Source | -1,214,000Source | -403,000Source | -1,004,000Source | -345,000Source | -2,870,000Source | -11,364,000Source | -15,088,000Source | -14,255,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -6,328,000Source | 64,316,000Source | -5,479,000Source | -13,308,000Source | -6,988,000Source | 17,695,000Source | -3,774,000Source | 31,966,000Source | -66,270,000Source | -89,264,000Source |
| Nonoperating Income (Expense)USD | — | — | -1,167,000Source | 72,289,000Source | 424,000Source | -7,609,000Source | 6,971,000Source | 24,069,000Source | 19,337,000Source | 72,914,000Source | — | — |
| Other Nonoperating Income (Expense)USD | — | — | — | — | 0Source | 0Source | -40,000Source | 0Source | — | — | -10,468,000Source | -12,311,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | 2,500,000Source | — | 841,000Source | — | 1,598,000Source | 1,533,000Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | 4,000Source | — | 302,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | — | — | — | — | — | — | — | — | — | 377,000Source |
| Unrealized Gain (Loss) on Investments | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 5,000Source | 996,000Source | 33,000Source | 6,000Source | 22,000Source | 8,000Source | 71,000Source | 2,995,000Source | 2,452,000Source | 377,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Income (Loss)USD | — | — | -4,844,000Source | -11,578,000Source | -7,022,000Source | -4,715,000Source | -8,035,000Source | -5,446,000Source | -21,806,000Source | -44,487,000Source | -68,795,000Source | -90,927,000Source |
| Other Nonoperating Income (Expense)USD | — | — | — | — | 0Source | 0Source | -40,000Source | 0Source | — | — | -10,468,000Source | -12,311,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -6,011,000Source | 60,711,000Source | -6,598,000Source | -12,324,000Source | -1,064,000Source | 18,623,000Source | -2,469,000Source | 28,427,000Source | -79,263,000Source | -103,238,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | — | — | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -628,000Source | -3,688,000Source | -1,214,000Source | -403,000Source | -1,004,000Source | -345,000Source | -2,870,000Source | -11,364,000Source | -15,088,000Source | -14,255,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -5,383,000Source | 64,399,000Source | -5,384,000Source | -11,921,000Source | -60,000Source | 18,968,000Source | 401,000Source | 39,791,000Source | -64,175,000Source | -88,983,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.29Source | 6.43Source | -0.87Source | -22.08Source | -4.42Source | 38.26Source | -5.63Source | 3.3Source | -9.16Source | -1Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.29Source | 1.44Source | -0.87Source | -22.08Source | -4.42Source | 10.1Source | -5.63Source | 0.5Source | -9.16Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 21,554,546Source | 10,005,379Source | 6,269,384Source | 602,822Source | 1,580,788Source | 462,539Source | 670,466Source | 9,672,199Source | 7,231,546Source | 89,076,078Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 21,554,546Source | 44,475,638Source | 6,269,384Source | 602,822Source | 1,580,788Source | 1,746,739Source | 670,466Source | 65,291,623Source | 7,231,546Source | — |
| Interest Expense (non-operating)USD | — | — | — | — | 2,000Source | 4,000Source | 3,000Source | 4,000Source | 21,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | 82,000Source | — | — | — | — | 0Source | 559,000Source | 2,021,000Source | 1,784,000Source |
| Costs and ExpensesUSD | — | — | 4,849,000Source | 12,574,000Source | 7,055,000Source | 4,721,000Source | 8,057,000Source | 5,454,000Source | 21,877,000Source | 47,482,000Source | 71,247,000Source | 91,304,000Source |
| General and Administrative ExpenseUSD | — | — | 3,505,000Source | 6,649,000Source | 4,651,000Source | 3,670,000Source | 6,356,000Source | 4,384,000Source | 16,250,000Source | 24,524,000Source | 30,947,000Source | 41,041,000Source |
| Interest Expense, DebtUSD | — | — | 8,000Source | 12,000Source | — | 4,000Source | — | 4,000Source | — | 45,000Source | 589,000Source | 1,272,000Source |
| Interest Income, OperatingUSD | — | — | 10,000Source | 70,000Source | — | 8,000Source | — | 8,000Source | — | 254,000Source | 505,000Source | — |
| Investment Income, InterestUSD | — | — | — | — | 10,000Source | 8,000Source | 19,000Source | 8,000Source | 29,000Source | — | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -6,328,000Source | 64,316,000Source | -5,479,000Source | -13,308,000Source | -6,988,000Source | 17,695,000Source | -3,774,000Source | 31,966,000Source | -66,270,000Source | -89,264,000Source |
| Nonoperating Income (Expense)USD | — | — | -1,167,000Source | 72,289,000Source | 424,000Source | -7,609,000Source | 6,971,000Source | 24,069,000Source | 19,337,000Source | 72,914,000Source | — | — |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | 90,000Source | 83,000Source | — | 88,000Source | — | 86,000Source | — | 329,000Source | 304,000Source | — |
| Research and Development ExpenseUSD | — | — | 1,088,000Source | 1,542,000Source | 2,067,000Source | 790,000Source | 1,388,000Source | 787,000Source | 4,492,000Source | 5,932,000Source | 14,276,000Source | 25,547,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | — | — | — | — | — | — | — | — | — | 377,000Source |
| Selling and Marketing ExpenseUSD | — | — | 201,000Source | 2,920,000Source | 215,000Source | 220,000Source | 216,000Source | 247,000Source | 917,000Source | 11,627,000Source | 17,583,000Source | 19,318,000Source |
| Interest Expense | — | — | — | — | — | —Source | — | —Source | — | — | — | — |
Offerings
Registration 333-295202
Filing attachments
ex99-1.htm · 8-K · 2026-08-14
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results Veris Health accelerated its commercial engagement with OSU-The James Veris Health implantable physiological monitor achieved development milestones towards upcoming FDA submission Lucid Diagnostics secured first laboratory benefit manager coverage policy for EsoGuard® Conference call and webcast to be held today, August 14, at 8:30 AM EDT NEW YORK, August 14, 202…
Read attachment ↗ex107.htm · S-8 · 2026-07-30
Calculation of Filing Fee Tables S-8 PAVmed Inc. ──────────────────────────────────── Table 1: Newly Registered Securities ──────────────────────────────────────── Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration F…
Read attachment ↗ex99-1.htm · 8-K · 2026-05-15
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results Veris Health progressed commercial expansion and advanced implantable physiological monitor development toward FDA submission Lucid Diagnostics continued building commercial momentum and strengthened its balance sheet ahead of key upcoming reimbursement milestones PAVmed advanced its relaunched medical device portfolio; evaluation of additional acquisition opportunit…
Read attachment ↗ex107.htm · S-3 · 2026-04-21
Calculation of Filing Fee Tables S-3 PAVmed Inc. ──────────────────────────────────── Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable ─────────────────────────────────────────────────────────────────────────────── Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate …
Read attachment ↗ex107.htm · S-8 · 2026-04-02
Calculation of Filing Fee Tables S-8 PAVmed Inc. ──────────────────────────────────── Table 1: Newly Registered Securities ──────────────────────────────────────── Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Regist…
Read attachment ↗ex107.htm · S-8 · 2026-04-02
Calculation of Filing Fee Tables S-8 PAVmed Inc. ──────────────────────────────────── Table 1: Newly Registered Securities ──────────────────────────────────────── Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration F…
Read attachment ↗